Polly A. Murphy - Net Worth and Insider Trading
Polly A. Murphy Net Worth
The estimated net worth of Polly A. Murphy is at least $157,642 dollars as of 2024-06-10. Polly A. Murphy is the Director of Atea Pharmaceuticals Inc and owns about 23,295 shares of Atea Pharmaceuticals Inc (AVIR) stock worth over $86,192. Polly A. Murphy is also the Director of Celcuity Inc and owns about 5,000 shares of Celcuity Inc (CELC) stock worth over $71,450. Details can be seen in Polly A. Murphy's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Polly A. Murphy has not made any transactions after 2022-11-22 and currently still holds the listed stock(s).
Transaction Summary of Polly A. Murphy
Polly A. Murphy Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Polly A. Murphy owns 2 companies in total, including Atea Pharmaceuticals Inc (AVIR) , and Celcuity Inc (CELC) .
Click here to see the complete history of Polly A. Murphy’s form 4 insider trades.
Insider Ownership Summary of Polly A. Murphy
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| AVIR | Atea Pharmaceuticals Inc | 2021-12-20 | director |
| CELC | Celcuity Inc | 2022-11-22 | director |
Polly A. Murphy Latest Holdings Summary
Polly A. Murphy currently owns a total of 2 stocks. Among these stocks, Polly A. Murphy owns 23,295 shares of Atea Pharmaceuticals Inc (AVIR) as of December 20, 2021, with a value of $86,192 and a weighting of 54.68%. Polly A. Murphy also owns 5,000 shares of Celcuity Inc (CELC) as of November 22, 2022, with a value of $71,450 and a weighting of 45.32%.
Latest Holdings of Polly A. Murphy
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| AVIR | Atea Pharmaceuticals Inc | 2021-12-20 | 23,295 | 3.70 | 86,192 |
| CELC | Celcuity Inc | 2022-11-22 | 5,000 | 14.29 | 71,450 |
Holding Weightings of Polly A. Murphy
Polly A. Murphy Form 4 Trading Tracker
According to the SEC Form 4 filings, Polly A. Murphy has made a total of 1 transactions in Atea Pharmaceuticals Inc (AVIR) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Atea Pharmaceuticals Inc is the acquisition of 12,000 shares on December 20, 2021, which cost Polly A. Murphy around $102,840.
According to the SEC Form 4 filings, Polly A. Murphy has made a total of 1 transactions in Celcuity Inc (CELC) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Celcuity Inc is the acquisition of 5,000 shares on November 22, 2022, which cost Polly A. Murphy around $48,400.
Insider Trading History of Polly A. Murphy
- 1
Polly A. Murphy Trading Performance
GuruFocus tracks the stock performance after each of Polly A. Murphy's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Polly A. Murphy is 5.13%. GuruFocus also compares Polly A. Murphy's trading performance to market benchmark return within the same time period. The performance of stocks bought by Polly A. Murphy within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Polly A. Murphy's insider trading performs compared to the benchmark.
Performance of Polly A. Murphy
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 12.91 | | | | | |
| Relative Return to S&P 500(%) | 16.11 | | | | | |
Polly A. Murphy Ownership Network
Polly A. Murphy Owned Company Details
What does Atea Pharmaceuticals Inc do?
Who are the key executives at Atea Pharmaceuticals Inc?
Polly A. Murphy is the director of Atea Pharmaceuticals Inc. Other key executives at Atea Pharmaceuticals Inc include director & 10 percent owner & President & CEO & and Chairman Jean-pierre Sommadossi , See Remarks Andrea Corcoran , and See Remarks Wayne Foster .
Atea Pharmaceuticals Inc (AVIR) Insider Trades Summary
Over the past 18 months, Polly A. Murphy made no insider transaction in Atea Pharmaceuticals Inc (AVIR). Other recent insider transactions involving Atea Pharmaceuticals Inc (AVIR) include a net sale of 57,916 shares made by Jean-pierre Sommadossi , a net sale of 15,870 shares made by Maria Arantxa Horga , and a net sale of 15,843 shares made by Andrea Corcoran .
In summary, during the past 3 months, insiders sold 1,006 shares of Atea Pharmaceuticals Inc (AVIR) in total and bought 0 shares, with a net sale of 1,006 shares. During the past 18 months, 127,954 shares of Atea Pharmaceuticals Inc (AVIR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 127,954 shares.
Atea Pharmaceuticals Inc (AVIR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Atea Pharmaceuticals Inc Insider Transactions
Polly A. Murphy Mailing Address
Above is the net worth, insider trading, and ownership report for Polly A. Murphy. You might contact Polly A. Murphy via mailing address: C/o Atea Pharmaceuticals, Inc., 125 Summer Street, Boston Ma 02110.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
